SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950135-97-001026
Filing Date
1997-02-28
Accepted
1997-02-28 00:00:00
Documents
1
Group Members
BIOTECHNOLOGY INVESTMENT GROUP L L C ET ALCOLLINSON HOWE VENTURE PARTNERS, INC.EDWARD BLECH TRUSTJEFFREY J. COLLINSONSCHRODER VENTURES LIMITED PARTNERSHIPSCHRODER VENTURES U.S. TRUSTSCHRODERS INCORPORATED
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 ALEXION PHARMACEUTICALS, INC. SC 13G/A 39797
  Complete submission text file 0000950135-97-001026.txt   42224
Mailing Address 25 SCIENCE PARK STE 360 NEW HAVEN CT 06511
Business Address 25 SCIENCE PARK STE 360 NEW HAVEN CT 06511 2037761790
ALEXION PHARMACEUTICALS INC (Subject) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 0731
Type: SC 13G/A | Act: 34 | File No.: 005-47771 | Film No.: 97548597
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1055 WASHINGTON BLVD C/O COLLINSON HOWE VENTURE PARTNERS INC STAMFORD CT 06901
Business Address 1055 WASHINGTON BOULEVARD C/O COLLINSON HOWE VENTURE PARTNERS INC STAMFORD CT 06901 2033247700
BIOTECHNOLOGY INVESTMENT GROUP L L C ET AL (Filed by) CIK: 0000937793 (see all company filings)

IRS No.: 061415704 | State of Incorp.: DE | Fiscal Year End: 1231